Inhibition of NOS enhances pulmonary vascular changes in stroke-prone spontaneously hypertensive rats

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 278, Issue 1 22-1, 2000, Pages

  Mathew, Rajamma ^a   Fan, Newton Y T ^a   Yuan, Ning ^a   Chander, Praveen N ^a   Gewitz, Michael H ^a   Stier Jr , Charles T ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acetylcholine; N( ) nitro L arginine; Nitric oxide synthase; Pulmonary circulation; Pulmonary hypertension

Indexed keywords

ACETYLCHOLINE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE VOLUME; HYPERTENSION; LUNG BLOOD VESSEL; LUNG CIRCULATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; STROKE;

EID: 0033968419     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.278.1.l81     Document Type: Article

References (43)

1. Adnot, S., B. Raffestin, S. Eddahibi, P. Braquet, and P.-E. Chabrier. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87: 155-162, 1991.
2. Aharinejad, S., D. E. Schraufnagel, P. Böck, C. A. MacKay, E. K. Larson, A. Miksovsky, and S. C. Marks, Jr. Spontaneously hypertensive rats develop pulmonary hypertension and hypertrophy of pulmonary venous sphincters. Am. J. Pathol. 148: 281-290, 1996.
3. Arnal, J.-F., A.-I. El Amrani, G. Chatellier, J. Ménard, and J.-B. Michel. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
4. Boulanger, C., and T. F. Lüscher. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587-590, 1990.
5. Celermajer, D. S., S. Cullen, and J. E. Deanfield. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87: 440-446, 1993.
6. Chander, P. N., and C. T. Stier, Jr. Stroke-prone spontaneously hypertensive rats: role of the renin-angiotensin system and nitric oxide. In: Asian Proceedings of the Fifth Asian Pacific Congress of Nephrology, edited by K. S. Chugh. New York: Oxford University Press, 1994, p. 299-310.
7. Devlin, A. M., A. O. Davidson, J. F. Gordon, A. M. Campbell, J. J. Morton, J. L. Reid, and A. F. Dominiczak. Vascular smooth muscle polyploidy in genetic hypertension: the role of AII. J. Hum. Hypertens. 9: 497-500, 1995.
8. Dinh Xuan, A. T., T. W. Higenbottam, C. Clelland, J. Pepke-Zaba, G. Cremona, and J. Wallwork. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br. J. Pharmacol. 99: 9-10, 1990.
9. Furchgott, R. F., and P. M. Vanhoutte. Endothelium-derived relaxing and contracting factors. FASEB J. 3: 2007-2018, 1989.
10. Garg, U., and A. Hassid. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777, 1989.
11. Guazzi, M. D., M. Alimento, M. Berti, C. Fiorentini, C. Galli, and G. Tamborini. Enhanced hypoxic pulmonary vasoconstriction in hypertension. Circulation 79: 337-343, 1989.
12. Hadrava, V., J. Tremblay, and P. Hamet. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 13: 589-597, 1989.
13. Janakidevi, K., C. Tiruppathi, P. J. del Vecchio, J. M. B. Pinheiro, and A. B. Malik. Growth characteristics of pulmonary artery smooth muscle cells from fawn-hooded rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 268: L465-L470, 1995.
14. Janssens, S. P., B. T. Thompson, C. R. Spence, and C. A. Hales. Functional and structural changes with hypoxia in pulmonary circulation of spontaneously hypertensive rats. J. Appl. Physiol. 77: 1101-1107, 1994.
15. Kiely, D. G., R. I. Cargill, and B. J. Lipworth. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans. Chest 110: 698-703, 1996.
16. Kiely, D. G., R. I. Cargill, N. M. Wheeldon, W. J. Coutie, and B. J. Lipworth. Haemodynamic and endocrine effects of type I angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc. Res. 33: 201-208, 1997.
17. Kouyoumdjian, C., S. Adnot, M. Levame, S. Eddahibi, H. Bousbaa, and B. Raffestin. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J. Clin. Invest. 94: 578-584, 1994.
18. 2-, cyanide and monocrotaline. J. Appl. Physiol. 71: 30-36, 1991.
19. Mathew, R., E. S. Gloster, B. T. Altura, and B. M. Altura. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy. Microcirc. Endothelium Lymphatics 6: 267-283, 1990.
20. Mathew, R., E. S. Gloster, T. Sundararajan, C. I. Thompson, G. A. Zeballos, and M. H. Gewitz. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension. J. Appl. Physiol. 82: 1493-1498, 1997.
21. Mathew, R., D. E. Guzowski, and E. S. Gloster. Effects of verapamil on monocrotaline-induced pulmonary artery hypertension and endothelial cell dysfunction in rats. Exp. Lung Res. 16: 627-644, 1990.
22. Mathew, R., G. A. Zeballos, H. Tun, and M. H. Gewitz. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats. Cardiovasc. Res. 30: 739-746, 1995.
23. Matsuoka, H., M. Nakata, K. Kohno, Y. Koga, G. Nomura, H. Toshima, and T. Imaizumi. Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 27: 14-18, 1996.
24. McMurtry, I. F., M. D. Petrun, A. Tucker, and J. T. Reeves. Pulmonary vascular reactivity in spontaneously hypertensive rat. Blood Vessels 16: 61-70, 1979.
25. Meyrick, B., W. Gamble, and L. Reid. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. Heart Circ. Physiol. 239: H692-H702, 1980.
26. Meyrick, B., and L. Reid. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab. Invest. 38: 188-200, 1978.
27. Millatt, L. J., E. M. Abdel-Rahman, and H. M. Siragy. Angiotensin II and nitric oxide: a question of balance. Regul. Pept. 81: 1-10, 1999.
28. Morrell, N. W., K. G. Morris, and K. R Stenmark. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 269: H1186-H1194, 1995.
29. Morrell, N. W., P. D. Upton, M. A. Higham, M. H. Yacoub, J. M. Polak, and J. Wharton. Angiotensin II stimulates proliferation of human pulmonary artery smooth muscle cells via the AT1 receptor. Chest 114: 90S-91S, 1998.
30. Ogata, J., M. Fujishima, K. Tamaki, Y. Nakatomi, T. Ishitsuka, and T. Omae. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. A pathological study. Virchows Arch. A Pathol. Anat. Histol. 394: 185-194, 1982.
31. Okada, K., M. L. Bernstein, W. Zhang, D. P. Schuster, and M. D. Botney. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am. J. Respir. Crit. Care Med. 158: 939-950, 1998.
32. Okamoto, K., and K. Aoki. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27: 282-293, 1963.
33. Okamoto, K., Y. Yamori, and A. Nagaoka. Establishment of the stroke-prone spontaneously hypertensive rats. Circ. Res. 34 and 35, Suppl. 1:I-143-I-153, 1974.
34. Olivari, M. T., C. Fiorentini, A. Polese, and M. D. Guazzi. Pulmonary hemodynamics and right ventricular function in hypertension. Circulation 57: 1185-1190, 1978.
35. Onda, T., S. Mashiko, M. Hamano, I. Tomita, and T. Tomita. Enhancement of endothelium-dependent relaxation in the aorta from stroke-prone spontaneously hypertensive rats at developmental stages of hypertension. Clin. Exp. Pharmacol. Physiol. 21: 857-863, 1994.
36. Pesquero, J. B, P. Boschcov, C. J. Lindsey, and A. C. M. Paiva. Pulmonary kinin metabolism and conversion of angiotensin I in spontaneously hypertensive rats. J. Hypertens. 10: 1479-1484, 1992.
37. Schuster, D. P., E. C. Crouch, W. C. Parks, T. Johnson, and M. D. Botney. Angiotensin converting enzyme expression in primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 154: 1087-1091, 1996.
38. Stier, C. T., Jr., I. F. Benter, S. Ahmad, H. Zuo, N. Selig, S. Roethel, S. Levine, and H. D. Itskovitz. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13: 115-121, 1989.
39. Stier, C. T., Jr., P. Chander, W. H. Gutstein, S. Levine, and H. D. Itskovitz. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am. J. Hypertens. 4: 680-687, 1991.
40. Stier, C. T., Jr., G. J. Sim, and S. Levine. Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats. Brain Res. 549: 354-356, 1991.
41. Vaziri, N. D., Z. Ni, and F. Oveisi. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248-1254, 1998.
42. Xu, Y., J.-F. Arnal, N. Hinglais, M.-D. Appay, I. Laboulandine, J. Bariety, and J.-B. Michel. Renal hypertensive angiopathy: comparison between chronic NO suppression and DOCA-salt intoxication. Am. J. Hypertens. 8: 167-176, 1995.
43. Zuckerman, A., P. N. Chander, G. A. Zeballos, and C. T. Stier, Jr. Regional renal nitric oxide release in stroke-prone spontaneously hypertensive rats. Hypertension 30: 1479-1486, 1997.